2 January 2023
Cyril Amarchand Mangaldas advises sellers on INR 9,500 crore acquisition by Advent
Advising firms
Deal team
12 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Shishir Vayttaden Lead | Cyril Amarchand Mangaldas | Partner | General Corporate and Competition Law | Not stated |
| Namrata Kolar Lead | Cyril Amarchand Mangaldas | Partner | Real Estate | Not stated |
| Biplab Lenin Lead | Cyril Amarchand Mangaldas | Partner | Pharma and Life Sciences | Not stated |
| Reeti Agarwal | Cyril Amarchand Mangaldas | Associate | Not stated | Not stated |
| Raksha Raina | Cyril Amarchand Mangaldas | Associate | Not stated | Not stated |
| Kashish Mahajan | Cyril Amarchand Mangaldas | Associate | Not stated | Not stated |
| Saumya Sharma | Cyril Amarchand Mangaldas | Associate | Not stated | Not stated |
| Tawishi Beria | Cyril Amarchand Mangaldas | Associate | Not stated | Not stated |
| Bhargav Joshi | Cyril Amarchand Mangaldas | Partner | Not stated | Not stated |
| Jaideep Kodali | Cyril Amarchand Mangaldas | Senior associate | Real Estate | Not stated |
| Kartik Jain | Cyril Amarchand Mangaldas | Senior associate | Pharma and Life Sciences | Not stated |
| Avaantika Kakkar | Cyril Amarchand Mangaldas | Partner | Competition Law | Not stated |
9 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- INR 95bn (INR 9,500 crore)
- What the figure measures
- Total transaction value
- Client
- Suven Pharmaceuticals LimitedSell-side
- Counterparties
- Advent (Buy-side)